Metlife Inc (NYSE: MET) has a price-to-earnings ratio that is above its average at 17.61x. The stock has a 36-month beta value of 1.05. Opinions on the stock are mixed, with 7 analysts rating it as a “buy,” 5 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for MET is 579.88M, and at present, short sellers hold a 1.00% of that float. On November 26, 2024, the average trading volume of MET was 3.19M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MET) stock’s latest price update
Metlife Inc (NYSE: MET)’s stock price has surge by 0.87relation to previous closing price of 86.59. Nevertheless, the company has seen a 4.76% surge in its stock price over the last five trading sessions. businesswire.com reported 2024-11-25 that KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–Global insurer MetLife celebrated the 5th anniversary of its Malaysia Center of Excellence (COE) on November 22, a key milestone reflecting growth in its hiring, operations, and community activities. Over the past five years, the COE has expanded to a robust team of 230 professionals working across global finance, technology, and other functions to support MetLife’s Asia operations. MetLife first opened its COE in 2019 with 50 employees, attracted by the.
MET’s Market Performance
Metlife Inc (MET) has experienced a 4.76% rise in stock performance for the past week, with a 6.01% rise in the past month, and a 16.42% rise in the past quarter. The volatility ratio for the week is 1.89%, and the volatility levels for the past 30 days are at 1.78% for MET. The simple moving average for the past 20 days is 6.22% for MET’s stock, with a 16.91% simple moving average for the past 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with TD Cowen repeating the rating for MET by listing it as a “Buy.” The predicted price for MET in the upcoming period, according to TD Cowen is $97 based on the research report published on October 09, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see MET reach a price target of $91. The rating they have provided for MET stocks is “Overweight” according to the report published on September 05th, 2024.
Goldman gave a rating of “Buy” to MET, setting the target price at $80 in the report published on January 08th of the current year.
MET Trading at 5.65% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.45% of gains for the given period.
Volatility was left at 1.78%, however, over the last 30 days, the volatility rate increased by 1.89%, as shares surge +5.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.87% upper at present.
During the last 5 trading sessions, MET rose by +4.76%, which changed the moving average for the period of 200-days by +29.39% in comparison to the 20-day moving average, which settled at $82.22. In addition, Metlife Inc saw 32.07% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MET starting from Separate Account II, who proposed sale 118 shares at the price of $82.60 back on Nov 21 ’24. After this action, Separate Account II now owns shares of Metlife Inc, valued at $9,747 using the latest closing price.
MetLife 401k Plan Large Cap Eq, the Affiliate discretionary manage of Metlife Inc, proposed sale 352 shares at $83.25 during a trade that took place back on Nov 07 ’24, which means that MetLife 401k Plan Large Cap Eq is holding shares at $29,304 based on the most recent closing price.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 1.0 for the gross margin
The net margin for Metlife Inc stands at 0.05. The total capital return value is set at 0.01. Equity return is now at value 13.31, with 0.55 for asset returns.
Based on Metlife Inc (MET), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at 0.8. The debt to equity ratio resting at 0.61. The interest coverage ratio of the stock is 5.05.
Currently, EBITDA for the company is 3.92 billion with net debt to EBITDA at -3.52. When we switch over and look at the enterprise to sales, we see a ratio of 0.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.17.
Conclusion
To sum up, Metlife Inc (MET) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
